Anmelden

Publikationen

Suche in 12944 Publikationen:

Zurücksetzen RSS
Zeitraum
73 Publikation(en)
07.12.2023
Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort.
Strahm C, Kahlert C, Güsewell S, Vuichard-Gysin D, Stocker R, Kuster S, Kohler P. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort. J Infect 2023
07.12.2023
Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort.
07.12.2023

J Infect 2023

Strahm Carol, Kahlert Christian, Güsewell Sabine, Vuichard-Gysin Danielle, Stocker Reto, Kuster Stefan, Kohler Philipp

Weiter
06.12.2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Passweg J, Baldomero H, Ansari M, Arber C, Chalandon Y, Daskalakis M, Diepold M, Diesch-Furlanetto T, Duchosal M, Gerull S, Güngör T, Heim D, Hitz F, Holbro A, Masouridi-Levrat S, Nair G, Novak U, Pabst T, Renner C, Stussi G, Schneidawind D, Schanz U, Wannesson L, Halter J, Swiss Blood Stem Cell Transplantation Group (SBST). Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematol Oncol 2023
06.12.2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
06.12.2023

Hematol Oncol 2023

Passweg Jakob R, Baldomero Helen, Ansari Marc, Arber Caroline, Chalandon Yves, Daskalakis Michael, Diepold Miriam, Diesch-Furlanetto Tamara, Duchosal Michel A, Gerull Sabine, Güngör Tayfun, Heim Dominik, Hitz Felicitas, Holbro Andreas, Masouridi-Levrat Stavroula, Nair Gayathri, Novak Urban, Pabst Thomas, Renner Christoph, Stussi Georg, Schneidawind Dominik, Schanz Urs, Wannesson Luciano, Halter Jörg P, Swiss Blood Stem Cell Transplantation Group (SBST)

Weiter
26.10.2023
Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma.
Gennari A, Rossi A, Sartoretti T, Maurer A, Skawran S, Treyer V, Sartoretti E, Curioni-Fontecedro A, Schwyzer M, Wälti S, Huellner M, Messerli M. Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma. Sci Rep 2023; 13:18357.
26.10.2023
Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma.
26.10.2023

Sci Rep 2023; 13:18357

Gennari Antonio G, Rossi Alexia, Sartoretti Thomas, Maurer Alexander, Skawran Stephan, Treyer Valerie, Sartoretti Elisabeth, Curioni-Fontecedro Alessandra, Schwyzer Moritz, Wälti Stephan, Huellner Martin W, Messerli Michael

Weiter
10.10.2023
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Lichtensteiger C, Koblischke M, Berner F, Jochum A, Sinnberg T, Balciunaite B, Purde M, Walter V, Abdou M, Hofmeister K, Kohler P, Vernazza P, Albrich W, Kahlert C, Zoufaly A, Traugott M, Kern L, Pietsch U, Kleger G, Filipovic M, Kneilling M, Cozzio A, Pop O, Bomze D, Bergthaler A, Hasan A, Aberle J, Flatz L. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023; 140:103118.
10.10.2023
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
10.10.2023

J Autoimmun 2023; 140:103118

Lichtensteiger Christa, Koblischke Maximilian, Berner Fiamma, Jochum Ann-Kristin, Sinnberg Tobias, Balciunaite Beatrice, Purde Mette-Triin, Walter Vincent, Abdou Marie-Therese, Hofmeister Kathrin, Kohler Philipp, Vernazza Pietro L, Albrich Werner, Kahlert Christian, Zoufaly Alexander, Traugott Marianna T, Kern Lukas, Pietsch Urs, Kleger Gian-Reto, Filipovic Miodrag, Kneilling Manfred, Cozzio Antonio, Pop Oltin, Bomze David, Bergthaler Andreas, Hasan Ali, Aberle Judith, Flatz Lukas

Weiter
20.09.2023
Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.
Daniore P, Moser A, Höglinger M, Probst-Hensch N, Imboden M, Vermes T, Keidel D, Bochud M, Ortega Herrero N, Baggio S, Chocano-Bedoya P, Rodondi N, Tancredi S, Wagner C, Cullati S, Stringhini S, Nusslé S, Veys-Takeuchi C, Zuppinger C, Harju E, Michel G, Frank I, Kahlert C, Albanese E, Crivelli L, Levati S, Amati R, Kaufmann M, Geigges M, Ballouz T, Frei A, Fehr J, von Wyl V. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies. Int J Public Health 2023; 68:1605812.
20.09.2023
Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.
20.09.2023

Int J Public Health 2023; 68:1605812

Daniore Paola, Moser André, Höglinger Marc, Probst-Hensch Nicole M, Imboden Medea, Vermes Thomas, Keidel Dirk, Bochud Murielle, Ortega Herrero Natalia, Baggio Stéphanie, Chocano-Bedoya Patricia O, Rodondi Nicolas, Tancredi Stefano, Wagner Cornelia, Cullati Stéphane, Stringhini Silvia, Nusslé Semira Gonseth, Veys-Takeuchi Caroline, Zuppinger Claire, Harju Erika, Michel Gisela, Frank Irène, Kahlert Christian, Albanese Emiliano, Crivelli Luca, Levati Sara, Amati Rebecca, Kaufmann Marco, Geigges Marco, Ballouz Tala, Frei Anja, Fehr Jan S, von Wyl Viktor

Weiter
08.09.2023
SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study.
Kohler P, Dörr T, Friedl A, Stocker R, Vuichard-Gysin D, Kuster S, Kahlert C, SURPRISE Study Group. SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study. Antimicrob Resist Infect Control 2023; 12:98.
08.09.2023
SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study.
08.09.2023

Antimicrob Resist Infect Control 2023; 12:98

Kohler Philipp, Dörr Tamara, Friedl Andree, Stocker Reto, Vuichard-Gysin Danielle, Kuster Stefan, Kahlert Christian, SURPRISE Study Group

Weiter
16.08.2023
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
Hensen T, Fässler D, O'Mahony L, Albrich W, Barda B, Garzoni C, Kleger G, Pietsch U, Suh N, Hertel J, Thiele I. The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients. Metabolites 2023; 13
16.08.2023
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
16.08.2023

Metabolites 2023; 13

Hensen Tim, Fässler Daniel, O'Mahony Liam, Albrich Werner, Barda Beatrice, Garzoni Christian, Kleger Gian-Reto, Pietsch Urs, Suh Noémie, Hertel Johannes, Thiele Ines

Weiter
12.08.2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Albrich W, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi J, Brand S. STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023; 58:678-691.
12.08.2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
12.08.2023

Aliment Pharmacol Ther 2023; 58:678-691

Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan

Weiter
04.08.2023
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
Finckh A, Ciurea A, Raptis C, Rubbert-Roth A. Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases. J Infect Dis 2023; 228:S13-S23.
04.08.2023
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
04.08.2023

J Infect Dis 2023; 228:S13-S23

Finckh Axel, Ciurea Adrian, Raptis Catherine E, Rubbert-Roth Andrea

Weiter
26.07.2023
Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Kahlert C, Strahm C, Güsewell S, Cusini A, Brucher A, Goppel S, Möller E, Möller J, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kuster S, Kohler P, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin Infect Dis 2023; 77:194-202.
26.07.2023
Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
26.07.2023

Clin Infect Dis 2023; 77:194-202

Kahlert Christian, Strahm Carol, Güsewell Sabine, Cusini Alexia, Brucher Angela, Goppel Stephan, Möller Elisabeth, Möller J. Carsten, Ortner Manuela, Ruetti Markus, Stocker Reto, Vuichard-Gysin Danielle, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kuster Stefan, Kohler Philipp, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group

Weiter
19.06.2023
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Kohler P, Babouee Flury B, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Ortner M, Rieder P, Ruetti M, Schmid H, Stocker R, Vuichard-Gysin D, Speer O, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert C, Kuster S, SURPRISE Study Group. Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study). Influenza Other Respir Viruses 2023; 17:e13167.
19.06.2023
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
19.06.2023

Influenza Other Respir Viruses 2023; 17:e13167

Kohler Philipp, Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio B, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J. Carsten, Ortner Manuela, Rieder Philippe, Ruetti Markus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Speer Oliver, Wiggli Benedikt, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kahlert Christian, Kuster Stefan, SURPRISE Study Group

Weiter
22.05.2023
Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study.
Sabatini S, Kaufmann M, Fadda M, Tancredi S, Noor N, Van Der Linden B, Cullati S, Frank I, Michel G, Harju E, Luedi C, Frei A, Ballouz T, Menges D, Fehr J, Kohler P, Kahlert C, Scheu V, Ortega N, Chocano-Bedoya P, Rodondi N, Stringhini S, Baysson H, Lorthe E, Zufferey M, Suggs L, Albanese E, Vincentini J, Bochud M, d'Acremont V, Nusslé S, Imboden M, Keidel D, Witzig M, Probst-Hensch N, von Wyl V. Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study. Int J Public Health 2023; 68:1605852.
22.05.2023
Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study.
22.05.2023

Int J Public Health 2023; 68:1605852

Sabatini Serena, Kaufmann Marco, Fadda Marta, Tancredi Stefano, Noor Nazihah, Van Der Linden Bernadette W A, Cullati Stéphane, Frank Irène, Michel Gisela, Harju Erika, Luedi Chantal, Frei Anja, Ballouz Tala, Menges Dominik, Fehr Jan S, Kohler Philipp, Kahlert Christian, Scheu Victor, Ortega Natalia, Chocano-Bedoya Patricia O, Rodondi Nicolas, Stringhini Silvia, Baysson Hélène, Lorthe Elsa, Zufferey Maria Caiata, Suggs L Suzanne, Albanese Emiliano, Vincentini Julia, Bochud Murielle, d'Acremont Valérie, Nusslé Samira Gonseth, Imboden Medea, Keidel Dirk, Witzig Melissa, Probst-Hensch Nicole M, von Wyl Viktor

Weiter
04.05.2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).
Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk N, Ntanasis-Stathopoulos I, Vangsted A, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hájek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos M, Sonneveld P, Ludwig H. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia 2023; 37:1175-1185.
04.05.2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).
04.05.2023

Leukemia 2023; 37:1175-1185

Terpos Evangelos, Musto Pellegrino, Engelhardt Monika, Delforge Michel, Cook Gordon, Gay Francesca, van de Donk Niels W C J, Ntanasis-Stathopoulos Ioannis, Vangsted Annette Juul, Driessen Christoph, Schjesvold Fredrik, Cerchione Claudio, Zweegman Sonja, Hájek Roman, Moreau Philippe, Einsele Hermann, San-Miguel Jesús F, Boccadoro Mario, Dimopoulos Meletios A, Sonneveld Pieter, Ludwig Heinz

Weiter
23.03.2023
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
Tancredi S, Ulyte A, Wagner C, Keidel D, Witzig M, Imboden M, Probst-Hensch N, Amati R, Albanese E, Levati S, Crivelli L, Kohler P, Cusini A, Kahlert C, Harju E, Michel G, Luedi C, Ortega N, Baggio S, Chocano-Bedoya P, Rodondi N, Ballouz T, Frei A, Kaufmann M, von Wyl V, Lorthe E, Baysson H, Stringhini S, Schneider V, Kaufmann L, Wieber F, Volken T, Zysset A, Dratva J, Cullati S, Corona Immunitas Research Group. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland. Int J Equity Health 2023; 22:51.
23.03.2023
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
23.03.2023

Int J Equity Health 2023; 22:51

Tancredi Stefano, Ulyte Agne, Wagner Cornelia, Keidel Dirk, Witzig Melissa, Imboden Medea, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Levati Sara, Crivelli Luca, Kohler Philipp, Cusini Alexia, Kahlert Christian, Harju Erika, Michel Gisela, Luedi Chantal, Ortega Natalia, Baggio Stéphanie, Chocano-Bedoya Patricia O, Rodondi Nicolas, Ballouz Tala, Frei Anja, Kaufmann Marco, von Wyl Viktor, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Schneider Valentine, Kaufmann Laurent, Wieber Frank, Volken Thomas, Zysset Annina, Dratva Julia, Cullati Stéphane, Corona Immunitas Research Group

Weiter
04.03.2023
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.
Tancredi S, Chiolero A, Wagner C, Haller M, Chocano-Bedoya P, Ortega N, Rodondi N, Kaufmann L, Lorthe E, Baysson H, Stringhini S, Michel G, Luedi C, Harju E, Frank I, Imboden M, Witzig M, Keidel D, Probst-Hensch N, Amati R, Albanese E, Corna L, Crivelli L, Vincentini J, Nusslé S, Bochud M, d'Acremont V, Kohler P, Kahlert C, Cusini A, Frei A, Puhan M, Geigges M, Kaufmann M, Fehr J, Cullati S, Corona Immunitas Research Group. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study. Infection 2023; 51:1453-1465.
04.03.2023
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.
04.03.2023

Infection 2023; 51:1453-1465

Tancredi Stefano, Chiolero Arnaud, Wagner Cornelia, Haller Moa Lina, Chocano-Bedoya Patricia O, Ortega Natalia, Rodondi Nicolas, Kaufmann Laurent, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Michel Gisela, Luedi Chantal, Harju Erika, Frank Irène, Imboden Medea, Witzig Melissa, Keidel Dirk, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Corna Laurie, Crivelli Luca, Vincentini Julia, Nusslé Semira Gonseth, Bochud Murielle, d'Acremont Valérie, Kohler Philipp, Kahlert Christian, Cusini Alexia, Frei Anja, Puhan Milo Alan, Geigges Marco, Kaufmann Marco, Fehr Jan S, Cullati Stéphane, Corona Immunitas Research Group

Weiter
09.02.2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Loo L, Waller M, Moreno C, Cole A, Stella A, Pop O, Jochum A, Ali O, Denes C, Hamoudi Z, Chung F, Aggarwal A, Low J, Patel K, Siddiquee R, Kang T, Mathivanan S, Mackay J, Jochum W, Flatz L, Hesselson D, Turville S, Neely G. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs. PLoS Biol 2023; 21:e3001967.
09.02.2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
09.02.2023

PLoS Biol 2023; 21:e3001967

Loo Lipin, Waller Matthew A, Moreno Cesar L, Cole Alexander J, Stella Alberto Ospina, Pop Oltin-Tiberiu, Jochum Ann-Kristin, Ali Omar Hasan, Denes Christopher E, Hamoudi Zina, Chung Felicity, Aggarwal Anupriya, Low Jason K K, Patel Karishma, Siddiquee Rezwan, Kang Taeyoung, Mathivanan Suresh, Mackay Joel P, Jochum Wolfram, Flatz Lukas, Hesselson Daniel, Turville Stuart G, Neely G Gregory

Weiter
07.11.2022
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Rieder P, Rütti M, Schmid H, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Kuster S, Kahlert C, Kohler P, SURPRISE Study Group. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. PLoS Med 2022; 19:e1004125.
07.11.2022
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
07.11.2022

PLoS Med 2022; 19:e1004125

Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal Onicio, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J Carsten, Rieder Philip, Rütti Markus, Schmid Hans-Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Wiggli Benedikt, Besold Ulrike, McGeer Allison, Risch Lorenz, Friedl Andree, Schlegel Matthias, Kuster Stefan, Kahlert Christian, Kohler Philipp, SURPRISE Study Group

Weiter
28.10.2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Friedrich M, Misselwitz B, Korte W, Bürgi J, Brand S. Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2. Aliment Pharmacol Ther 2022; 57:103-116.
28.10.2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
28.10.2022

Aliment Pharmacol Ther 2022; 57:103-116

Woelfel Simon, Dütschler Joel, König Marius, Graf Nicole, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Wyss Jacqueline, Krupka Niklas, Albrich Werner, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Friedrich Matthias, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan

Weiter
13.10.2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Raptis C, Berger C, Ciurea A, Andrey D, Polysopoulos C, Lescuyer P, Maletic T, Riek M, Scherer A, von Loga I, Safford J, Lauper K, Möller B, Vuilleumier N, Finckh A, Rubbert-Roth A. Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Front Immunol 2022; 13:1016927.
13.10.2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
13.10.2022

Front Immunol 2022; 13:1016927

Raptis Catherine E, Berger Christoph T, Ciurea Adrian, Andrey Diego O, Polysopoulos Christos, Lescuyer Pierre, Maletic Tanja, Riek Myriam, Scherer Almut, von Loga Isabell, Safford Judith, Lauper Kim, Möller Burkhard, Vuilleumier Nicolas, Finckh Axel, Rubbert-Roth Andrea

Weiter
20.09.2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye B, Giezendanner S, Grutters J, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer A, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi J. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials 2022; 23:790.
20.09.2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
20.09.2022

Trials 2022; 23:790

Boesing Maria, Abig Kristin, Brändle Michael, Brutsche Martin, Burri Emanuel, Frye BjöC, Giezendanner Stéphanie, Grutters Jan C, Haas Philippe, Heisler Justian, Jaun Fabienne, Leuppi-Taegtmeyer Anne Barbara, Lüthi-Corridori Giorgia, Müller-Quernheim Joachim, Nüesch Reto, Pohl Wolfgang, Rassouli Frank, Leuppi Jörg D

Weiter

Wir verwenden Cookies und Tracking-Technologien gemäss unserer Datenschutz- bestimmungen, um Ihnen die bestmögliche Web-Erfahrung zu ermöglichen. Zur Datenschutzerklärung